F-group (family)
4983.1.1.1 IDO
Ligands and drugs
242
Member domains
69
with ligand contacts (≤ 4 Å)
28.5% of members
39
with DrugDomain annotations
16.1% of members
30
with a DrugBank compound
12.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 4983.1.1.1 belongs to X-group 4983 Indoleamine 2,3-dioxygenase N-terminal subdomain, which has 1 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02070 | KYN | Kynurenine | 3 |
| DB00150 | TRP | Tryptophan | 1 |
| DB00435 | — | — | 1 |
| DB09061 | — | Cannabidiol | 1 |
| DB14011 | — | — | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 14 |
| NFK | N'-Formylkynurenine | 5 |
| A1H93 | (R)-[1-[2,5-bis(fluoranyl)-4-methoxy-phenyl]-1,2,3-triazol-4-yl]-(6-cyclopropylimidazo[1,5-a]pyrazin-5-yl)methanol | 4 |
| CL | CHLORIDE ION | 4 |
| HQJ | 4-(3-chlorophenyl)-1H-imidazole | 4 |
| KYN | (2S)-2-amino-4-(2-aminophenyl)-4-oxobutanoic acid | 3 |
| A1H60 | (~{R})-(2-cyclopropylimidazo[5,1-b][1,3]thiazol-3-yl)-(1-phenyl-1,2,3-triazol-4-yl)methanol | 2 |
| A1H6R | (~{S})-[(7~{a}~{R})-2-cyclopentyl-5,6,7,7~{a}-tetrahydroimidazo[5,1-b][1,3]thiazol-3-yl]-cyclohexyl-methanol | 2 |
| A1H6T | (~{R})-(6-chloranylimidazo[1,5-a]pyridin-5-yl)-(1-phenyl-1,2,3-triazol-4-yl)methanol | 2 |
| A1H6U | (~{S})-cyclohexyl(imidazo[1,5-a]pyridin-5-yl)methanol | 2 |
| A1H6V | (~{R})-(2-cyclopropylimidazo[5,1-b][1,3]thiazol-3-yl)-[1-(1~{H}-indol-5-yl)-1,2,3-triazol-4-yl]methanol | 2 |
| TRP | TRYPTOPHAN | 2 |
| A1JLA | 2-[4-[[(1~{R},2~{S},6~{S},8~{R})-2-[(4-ethynylphenyl)carbamoyloxymethyl]-9,9-dimethyl-4-azatricyclo[6.1.1.0^{2,6}]decan-4-yl]sulfonyl]-3-methyl-phenyl]-2-methyl-propanoic acid | 1 |
| A1JLB | 2-[4-[[(1~{R},2~{R},6~{S},8~{R})-2-[3-[(4-ethynylphenyl)amino]-3-oxidanylidene-propyl]-9,9-dimethyl-4-azatricyclo[6.1.1.0^{2,6}]decan-4-yl]sulfonyl]phenyl]-2-methyl-propanoic acid | 1 |
| A1JLD | [(1~{R},2~{S},6~{S},8~{R})-4-(4-~{tert}-butyl-2-methyl-phenyl)sulfonyl-9,9-dimethyl-4-azatricyclo[6.1.1.0^{2,6}]decan-2-yl]methyl ~{N}-(4-ethynylphenyl)carbamate | 1 |
| A1JLE | [(1~{R},2~{S},6~{S},8~{R})-4-(4-~{tert}-butylphenyl)sulfonyl-9,9-dimethyl-4-azatricyclo[6.1.1.0^{2,6}]decan-2-yl]methyl ~{N}-(4-ethynylphenyl)carbamate | 1 |